Publikationen in Zusammenarbeit mit Forschern von Hospital Virgen de La Luz de Cuenca (13)

2021

  1. Mortality of hemodialysis patients is associated with their clinical situation at the start of treatment

    Nefrologia, Vol. 41, Núm. 4, pp. 461-466

2016

  1. Study of glomerulonephritis evolution in Castilla-La Mancha (GLOMANCHA) between 1994 and 2008

    Nefrologia, Vol. 36, Núm. 3, pp. 237-242

2004

  1. Perceived health-related quality of life and comorbidity in diabetic patients starting dialysis (CALVIDIA study)

    Journal of Nephrology, Vol. 17, Núm. 4, pp. 544-551

  2. Perceived mental health at the start of dialysis as a predictor of morbidity and mortality in patients with end-stage renal disease (CALVIDIA study)

    Nephrology Dialysis Transplantation, Vol. 19, Núm. 9, pp. 2347-2353

1992

  1. ASPECTOS EPIDEMIOLOGICOS DEL FRACASO RENAL AGUDO EN EL AREA SANITARIA DE CUENCA

    Nefrologia, Vol. 12, Núm. SUPPL. 4, pp. 87-91

  2. Growth hormone response to acute growth hormone releasing hormone administration in uraemic patients on haemodialysis

    Nephrology Dialysis Transplantation, Vol. 7, Núm. 3, pp. 246-250

1991

  1. Acute interstitial nephritis induced by ethambutol [13]

    Nephron

  2. Anticardiolipin antibodies and lupus anticoagulant in end-stage renal disease

    Nephrology Dialysis Transplantation, Vol. 6, Núm. 8, pp. 543-547

  3. HEMOLISIS Y PANCREATITIS AGUDA EN HEMODIALISIS [3]

    Nefrologia

  4. MANEJO DEL SINDROME ANTIFOSFOLIPIDO

    Nefrologia

1990

  1. SINDROME ANTIFOSFOLIPIDO Y TROMBOSIS DE ACCESOS VASCULARES PARA HEMODIALISIS

    Nefrologia, Vol. 10, Núm. 3, pp. 311-313

  2. Treatment of anemia with recombinant human erythropoietin and the bone marrow response in uremic patients undergoing periodic hemodialysis

    Revista clínica española, Vol. 186, Núm. 9, pp. 419-422

1989

  1. Prolactin's response to acute administration of growth hormone releasing hormone in uremic patients

    Revista Clinica Espanola, Vol. 185, Núm. 8, pp. 399-401